Rewiring cancer: 3D genome determinants of cancer hallmarks
Current Opinion in Genetics & Development · 2025-04 · 91 · 102307
DOI: 10.1016/j.gde.2024.102307 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Current Opinion in Genetics & Development, 2025-04. Verfasst von Maria E Amodeo und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Dana-Farber Cancer Institute, Boston, MA, USA; Broad Institute, Cambridge, MA, USA. Hauptthemen laut MEDLINE: Neoplasms, Genome, Human. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, National Institutes of Health National Cancer Institute, American Gastroenterological Association.
Abstract (Originalsprache)
In modern cancer biology, Hanahan and Weinberg's classic depiction of the Hallmarks of Cancer serves as a heuristic for understanding malignant phenotypes [1]. Genetic determinants of these phenotypes promote cancer induction and progression, and these mutations drive current approaches to understanding and treating cancer. Meanwhile, for over a century, pathologists have noted that profound alterations of nuclear structure accompany transformation, integrating these changes into diagnostic classifications (Figure 1). Nevertheless, the relationship of nuclear organization to malignant phenotypes has lagged. Recent advances yield profound insight into the 3D genome's relationship with cancer phenotypes, suggesting that spatial genome organization influences many, if not all, of these malignant features. Here, we highlight recent discoveries elucidating connections between 3D genome organization and cancer phenotypes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Pathology, Dana-Farber Cancer Institute, Boston, MA, USA; Broad Institute, Cambridge, MA, USA.
- Department of Radiation Oncology, Duke University School of Medicine, Durham, NC, USA. Electronic address: christine.eyler@duke.edu.
- Department of Pathology, Dana-Farber Cancer Institute, Boston, MA, USA; Broad Institute, Cambridge, MA, USA; Department of Pathology, Harvard Medical School, Boston, MA, USA. Electronic address: sarah_johnstone@dfci.har…
Förderung
- NCI NIH HHS
- National Institutes of Health National Cancer Institute
- American Gastroenterological Association
- V Foundation
Zitieren
APA
Amodeo, M. E., Eyler, C. E., & Johnstone, S. E. (2025). Rewiring cancer: 3D genome determinants of cancer hallmarks. Current Opinion in Genetics & Development, 91, 102307. https://doi.org/10.1016/j.gde.2024.102307
Vancouver
Amodeo ME, Eyler CE, Johnstone SE. Rewiring cancer: 3D genome determinants of cancer hallmarks. Current Opinion in Genetics & Development. 2025;91:102307. doi:10.1016/j.gde.2024.102307
BibTeX
@article{Amodeo2025,
author = {Amodeo, Maria E and Eyler, Christine E and Johnstone, Sarah E},
title = {Rewiring cancer: 3D genome determinants of cancer hallmarks},
journal = {Current Opinion in Genetics & Development},
year = {2025},
volume = {91},
pages = {102307},
doi = {10.1016/j.gde.2024.102307}
}
EUVIMED